Invitrocue Appoints Global Insurance Advisor

IVQ Appoints Global Insurance Advisor

06 May, 2019: Innovative life sciences company Invitrocue Limited (ASX: IVQ), (‘Invitrocue’ or ‘the Company’), is please to announce the appointment of Dr Sharifuddin Abdul Wahab as Global Insurance Advisor.

In his role at Invitrocue, Dato Dr Wahab will advise and support the Company’s global insurance strategy for its Onco Patient-Derived Organoid (‘Onco-PDO’) service.

Dato Dr Wahab is a Veterinary doctor by training who has extensive experience in the commercial sector. He is a Chairman Board of Commissioners of KSK Insurance Indonesia, one of the region’s largest insurance companies. Prior to this, he held a number of roles at Schmidt Scientific including CEO of Schmidt BioMedTech Asia.